WHO ICTRP trial
Role of metformin in patients having psoriasis and metabolic syndrome
CTRI/2017/12/010801 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2017/12/010801 |
|---|---|
| Public title | Role of metformin in patients having psoriasis and metabolic syndrome |
| Scientific title | EFFECT OF INSULIN SENSITIZER METFORMIN ON MARKERS OF ENDOTHELIAL DYSFUNCTION IN PSORIASIS PATIENTS WITH METABOLIC SYNDROME: A RANDOMISED CONTROL STUDY |
| Primary sponsor | Post graduate Institute of Medical Education and Research PGIMER Chandigarh |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: null- Psoriasis with metabolic syndrome |
| Interventions | Intervention1: METFORMIN: Insulin sensitizer Intervention2: METFORMIN, PSORIASIS TREATMENT, LIFESTYLE INTERVENTION: Metformin 500 mg OD orally for 12 weeks Prescribed psoriasis treatment Lifestyle intervention determined as at least 150 min… |
| Registration date | Jul 12, 2017 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: